Diabetes

News

Lilly ups spend on diabetes, obesity drug production to $9bn

Eli Lilly is determined not to be left behind when it comes to manufacturing capacity for new diabetes and obesity therapies, raising its spending on a new plant in Indian

News

Boehringer will use Walgreens trials unit for obesity trial

Walgreens’ plans to disrupt the clinical trials sector have taken a step forward with a high-profile partnership with Boehringer Ingelheim.

News

Biotts claims a first with insulin delivery across skin

Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.

News

EMA finds no suicide risk with GLP-1 diabetes, obesity drugs

There is no evidence of an increased risk of suicidal or self-injurious thoughts and actions with GLP-1 agonists used to treat diabetes and obesity, according to the EU me

News

digital health technologies for diabetes management

Digital diabetes tools ‘of little benefit and raise costs’

The recently formed Peterson Health Technology Institute (PHTI) has published its first assessment of the cost-effectiveness of digital health technologies (DHTs), focusin

News

FDA clears first OTC glucose biosensor, from Dexcom

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time.

Lilly ups spend on diabetes, obesity drug production to $9bn

Boehringer will use Walgreens trials unit for obesity trial

Biotts claims a first with insulin delivery across skin

EMA finds no suicide risk with GLP-1 diabetes, obesity drugs

Digital diabetes tools ‘of little benefit and raise costs’

FDA clears first OTC glucose biosensor, from Dexcom

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Diabetes

Editor's Picks